Weight Loss in Adults Using Semaglutide (Real-world Study)

NCT07627074 · clinicaltrials.gov ↗

COMPLETED

Status

237211

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Semaglutide

Sponsor

Novo Nordisk A/S